NCT03899103View on ClinicalTrials.gov

Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

September 5, 2023

Study Completion Date

December 24, 2023

Conditions

Steroid-Dependent Nephrotic Syndrome

Interventions

DRUG

Rituximab

First course Course Rituximab at Randomization.

DRUG

Mycophenolate Mofetil

Addition of Maintenance Mycophenolate Mofetil from 4 Month onwards

Trial Locations (1)

700014

Nilratan Sircar Medical College and Hospital, Kolkata

All Listed Sponsors

collaborator

Heidelberg University

OTHER

lead

Nilratan Sircar Medical College

OTHER_GOV

NCT03899103 - Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome | Biotech Hunter | Biotech Hunter